SCHEMBL1063543

SCHEMBL1063543

CCCn1c2c(c(=O)n(CCC)c1=O)NCN2C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 5/20 0.40
▸ ADORA2B P29275 5/20 0.40
▸ PDE4A P27815 3/20 0.40
▸ PDE4B Q07343 3/20 0.40
▸ PDE4C Q08493 3/20 0.40
▸ PDE4D Q08499 3/20 0.40
▸ POLB P06746 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ ADORA1 P30542 5/20 0.38
▸ SIRT1 Q96EB6 1/20 0.38
▸ SIRT3 Q9NTG7 1/20 0.38
▸ SIRT5 Q9NXA8 1/20 0.38
▸ CYP1A2 P05177 2/20 0.37
▸ PMP22 Q01453 2/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ BLM P54132 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ GMNN O75496 1/20 0.37
▸ LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21891275 0.69 ALDH1A1 (0.33) ADORA2AADORA2BPDE4APDE4BPDE4C
SCHEMBL8443038 0.67 POLB (0.39) ADORA2AADORA2BPDE4APDE4BPDE4C
SCHEMBL331903 0.66 PDE4A (0.47) ADORA2AADORA2BPDE4APDE4BPDE4C
SCHEMBL16060128 0.63 ADORA2B (0.37) ADORA2AADORA2BPDE4APDE4BPDE4C
SCHEMBL17935736 0.61 APEX1 (0.54) ADORA2AADORA2BPDE4APDE4BPDE4C
SCHEMBL2462138 0.60 KDM4E (0.40) MEN1LMNAKMT2A
SCHEMBL23020227 0.60 GSK3A (0.50) ADORA2AADORA2BPDE4APDE4BPDE4C
SCHEMBL21974369 0.60 GSK3A (0.50) ADORA2AADORA2BPDE4APDE4BPDE4C
SCHEMBL13108310 0.60 PDE4A (0.48) ADORA2AADORA2BPDE4APDE4BPDE4C
SCHEMBL1061386 0.60 ALDH1A1 (0.51) ADORA2AADORA2BPDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268641-A2 HETEROCYCLIC COMPOUNDS AS ADENOSINE RECEPTOR ANTAGONIST Advinus Therapeutics Pvt. Ltd. (IN) 2011-01-05 — — EP claimed
WO-2009118759-A2 HETEROCYCLIC COMPOUNDS AS ADENOSINE RECEPTOR ANTAGONIST ADVINUS THERAPEUTICS PVT. LTD., (IN) 2009-10-01 — — WO claimed
Send feedback